Jaume Mora

25.4k total citations · 1 hit paper
216 papers, 5.5k citations indexed

About

Jaume Mora is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jaume Mora has authored 216 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Neurology, 79 papers in Molecular Biology and 47 papers in Cancer Research. Recurrent topics in Jaume Mora's work include Neuroblastoma Research and Treatments (96 papers), Cancer, Hypoxia, and Metabolism (39 papers) and Sarcoma Diagnosis and Treatment (26 papers). Jaume Mora is often cited by papers focused on Neuroblastoma Research and Treatments (96 papers), Cancer, Hypoxia, and Metabolism (39 papers) and Sarcoma Diagnosis and Treatment (26 papers). Jaume Mora collaborates with scholars based in Spain, United States and Germany. Jaume Mora's co-authors include William L. Gerald, Carmen de Torres, Nai‐Kong V. Cheung, Manel Esteller, Carlos Cordon‐Cardo, Cinzia Lavarino, Scott W. Lowe, Yuri Lazebnik, Paola Capodieci and David Polsky and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Jaume Mora

205 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

2001 769 citations Jaume Mora et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jaume Mora	3.1k	1.4k	1.2k	1.0k	715	216	5.5k
Svetlana Pack	3.1k 1.0×	578 0.4×	1.5k 1.3×	1.1k 1.0×	1.4k 1.9×	130	6.5k
Shakeel Modak	1.7k 0.5×	2.6k 1.9×	1.5k 1.2×	869 0.9×	827 1.2×	160	4.7k
Annunziato Mangiola	2.2k 0.7×	1.1k 0.8×	556 0.5×	1.8k 1.8×	438 0.6×	117	5.2k
Johannes H. Schulte	4.3k 1.4×	2.1k 1.5×	1.3k 1.0×	2.1k 2.1×	368 0.5×	176	6.3k
Lauri Eklund	2.2k 0.7×	606 0.4×	1.1k 0.9×	700 0.7×	359 0.5×	63	4.6k
Michael D. Hogarty	3.9k 1.3×	4.7k 3.4×	1.5k 1.2×	2.3k 2.3×	345 0.5×	110	6.9k
Maria Zieleńska	3.0k 1.0×	459 0.3×	1.1k 0.9×	1.5k 1.5×	2.2k 3.0×	148	5.5k
Janice A. Royds	2.1k 0.7×	306 0.2×	1.4k 1.1×	682 0.7×	469 0.7×	100	3.7k
Yukihiko Sonoda	1.6k 0.5×	592 0.4×	596 0.5×	642 0.6×	552 0.8×	224	4.6k
Libero Lauriola	1.1k 0.3×	1.1k 0.8×	637 0.5×	473 0.5×	496 0.7×	179	4.3k

Countries citing papers authored by Jaume Mora

Since Specialization

Citations

This map shows the geographic impact of Jaume Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Mora more than expected).

Fields of papers citing papers by Jaume Mora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Mora. The network helps show where Jaume Mora may publish in the future.

Co-authorship network of co-authors of Jaume Mora

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Mora. A scholar is included among the top collaborators of Jaume Mora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Mora. Jaume Mora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paco, Sonia, Federica Zito Marino, Eva Rodríguez, et al.. (2025). Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma. Neuro-Oncology Advances. 7(1). vdaf132–vdaf132.

Molnar, Cristina, et al.. (2024). Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose–response relationship in Drosophila. Open Biology. 14(7). 240043–240043. 2 indexed citations

Mora, Jaume, Godfrey Chi Fung Chan, Daniel A. Morgenstern, et al.. (2024). Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma.. Journal of Clinical Oncology. 42(16_suppl). 10032–10032. 2 indexed citations

Villasante, Aránzazu, et al.. (2024). Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model. Cancers. 16(5). 1060–1060. 1 indexed citations

Pascual‐Pasto, Guillem, Helena Castillo‐Ecija, Mònica Vilà-Ubach, et al.. (2023). Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma. Biochemical Pharmacology. 208. 115408–115408. 7 indexed citations

Muñoz, Juan Pablo, et al.. (2023). Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes. Cancers. 15(19). 4837–4837. 13 indexed citations

Sánchez-Molina, Sara, Víctor Sánchez‐Margalet, Luis de la Cruz‐Merino, et al.. (2022). Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers. 14(21). 5473–5473. 6 indexed citations

Gouveia, Leonor, Ana Angulo‐Urarte, Laia Muixí, et al.. (2022). The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib. EMBO Molecular Medicine. 14(7). e15619–e15619. 35 indexed citations

Muñoz‐Vendrell, Albert, et al.. (2021). Functional neuroimaging in nonepileptiform electroencephalographic patterns in status epilepticus. Acta Neurologica Scandinavica. 144(6). 687–694. 2 indexed citations

10.

Martínez-Lage, Marta, Raúl Torres, M. Cruz Martín, et al.. (2020). In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells. Nature Communications. 11(1). 5060–5060. 79 indexed citations

11.

Pignata, Laura, Orazio Palumbo, Flavia Cerrato, et al.. (2020). Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors. Cancers. 12(11). 3411–3411. 7 indexed citations

12.

Royer‐Pokora, Brigitte, Maike Busch, Mathias Schmidt, et al.. (2020). Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations. Cancers. 13(1). 60–60. 7 indexed citations

13.

Botteri, Gaia, Helena Castillo‐Ecija, Guillem Pascual‐Pasto, et al.. (2018). Tissue Compatibility of SN‐38‐Loaded Anticancer Nanofiber Matrices. Advanced Healthcare Materials. 7(15). e1800255–e1800255. 5 indexed citations

14.

Paco, Sonia, Nagore G. Olaciregui, Guillem Pascual‐Pasto, et al.. (2017). Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8. Journal of Controlled Release. 255. 108–119. 34 indexed citations

15.

Pascual‐Pasto, Guillem, Nagore G. Olaciregui, Javier A.W. Opezzo, et al.. (2017). Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier. Journal of Controlled Release. 264. 34–44. 8 indexed citations

16.

Pascual‐Pasto, Guillem, Francisco Cano, Mònica Vilà-Ubach, et al.. (2015). SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery. Biomaterials. 79. 69–78. 39 indexed citations

17.

García, Idoia, José Ríos, Gema Doménech, et al.. (2012). A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clinical Cancer Research. 18(7). 2012–2023. 51 indexed citations

18.

Preter, Katleen De, Joëlle Vermeulen, Benedikt Brors, et al.. (2010). Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature. Clinical Cancer Research. 16(5). 1532–1541. 65 indexed citations

19.

Falip, Mercè, Jordi Bruna, Antoni Palasí, et al.. (2010). Refractory nonconvulsive status epilepticus in Creutzfeldt‐Jakob disease. Epileptic Disorders. 12(3). 239–242. 14 indexed citations

20.

Aramayona, J. J., et al.. (1996). Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. American Journal of Veterinary Research. 57(4). 547–553. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact